Incretin serum level as a biomarker of insulin resistance in acne vulgaris patients.
Fathia M KhattabManal FawzyPublished in: Journal of cosmetic dermatology (2022)
Patients with acne vulgaris are prone to have insulin resistance. Insulin resistance in patients with acne vulgaris is negatively correlated with Incretin. Serum Incretin may be expected to be a biomarker for diagnosing acne vulgaris patients with insulin resistance. The severity of acne vulgaris may have no obvious correlation with insulin resistance and serum incretin.
Keyphrases
- insulin resistance
- hidradenitis suppurativa
- adipose tissue
- high fat diet
- metabolic syndrome
- type diabetes
- polycystic ovary syndrome
- end stage renal disease
- skeletal muscle
- newly diagnosed
- high fat diet induced
- ejection fraction
- chronic kidney disease
- prognostic factors
- glycemic control
- peritoneal dialysis
- weight loss